Ranbaxy Laboratories, India’s biggest drug maker by revenue, said it expects sales to increase by at least 10 per cent in 2012 as it takes advantage of expiring drug patents in the United States, its biggest market. Ranbaxy, which launched a generic version of cholesterol drug Lipitor in the US market in December, reported a fourth-quarter loss equivalent to $606 million. Sales, however, soared 79.2 per cent to $759.37 million in the quarter to Dec.31 from a year earlier, and were up 16.6 per cent at $2.02 billion for the full year.
GMT 09:43 2018 Tuesday ,23 January
Global unemployment down but working poverty rampantGMT 15:13 2018 Sunday ,21 January
All you need to know about Davos 2018GMT 22:33 2018 Saturday ,20 January
Calls for action over dirty money flowingGMT 04:42 2018 Saturday ,20 January
Storm caused 90 mn euros in damage: Dutch insurersGMT 07:06 2018 Friday ,19 January
China economy rebounds in 2017 with 6.9% growthGMT 11:35 2018 Thursday ,18 January
'Massive' infrastructure spending needed in AfricaGMT 14:29 2018 Wednesday ,17 January
GE takes one-off hit of $6.2 bn linked to insurance activitiesGMT 18:55 2018 Tuesday ,16 January
London stock market edges to new high

Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Maintained and developed by Arabs Today Group SAL.
All rights reserved to Arab Today Media Group 2025 ©
Send your comments
Your comment as a visitor